2025年12月

Healthcare innovation is taking an exciting turn with the development of OX40 ligand inhibitors, a breakthrough class of therapies showing real promise for patients struggling with inflammatory and autoimmune disorders. The OX40 Ligand Inhibitors Market ... もっと読む

Human papillomavirus research has traditionally centered on cervical and throat cancers, yet a growing body of evidence reveals its significant role in skin malignancies. Beta-HPV strains have been implicated in various cutaneous tumors, particularly affe ... もっと読む

ObjectiveDelveInsight was engaged by a leading U.S.-based pharmaceutical company with expertise in drug delivery devices to conduct a comprehensive assessment of the dissolvable microneedle technology (dMTS) landscape. The primary objective was to identif ... もっと読む

ObjectiveDelveInsight was engaged by a mid-sized pharmaceutical company headquartered in the United States to provide a comprehensive Go-To-Market (GTM) strategy assessment for their biosimilar portfolio in Europe. The client sought detailed insights into ... もっと読む

ObjectiveTo perform a comprehensive epidemiological assessment of Cutaneous Squamous Cell Carcinoma (cSCC), with a focus on understanding the incidence among solid organ transplant recipients across multiple geographies.Gain actionable epidemiological ins ... もっと読む

↑このページのトップヘ